According to Lexaria Bioscience latest financial reports the company has an operating margin of -28.89%, an increase of 11.45% to 2022. At the end of 2022 company had an operating margin of -25.92%.
Year | Operating Margin | Change |
---|---|---|
2023 | -28.89% | 11.45% |
2022 | -25.92% | 229.37% |
2021 | -7.87% | -27.07% |
2020 | -10.79% | - |